Thapsigargin (a specific SERCA inhibitor) causes enhanced bacterial infection, NF-κB activation and IL-8 release in airway epithelial cells in a cytosolic calcium dependent manner [16]. Here, CXCL8 is linked to bacterial infectious disease.